Within the life sciences, foundational technological breakthroughs over the past decade are driving continued renewal in the discovery and production environments. Precision gene editing, exponential declines in DNA sequencing / synthesis costs, and an increasing ability for computation to grow our understanding of life through AI-enabled programs, among other advances, demand new approaches, tools and solutions.

In MedTech, we see a continued push for better patient experiences and increased cost effectiveness. Solutions that address these dynamics and improve outcomes, such as MIS & RAS, will continue to expand and in turn increase complexity, quality, and design requirements for the MedTech supply chain.